Inhaled insulin, known as Afrezza, provides a needle-free option for managing Type 1 diabetes. The treatment is currently approved for adults, with promising studies for children. Dr. Veena Watwe from ...

Five presentations will showcase data on inhaled insulin from the INHALE-1 and INHALE-3 studies at the ATTD 2025 conference. What safety warnings are associated with Afrezza? Afrezza can cause ...

MannKind's long-awaited inhaled insulin product Afrezza has been approved in the US. The approval on Friday is a triumph for the firm's founder and chief executive Alfred Mann, who has persisted ...

Get Instant Summarized Text (Gist) Inhaled technosphere insulin (TI-Afrezza) offers a viable alternative for adults with type 1 diabetes, providing a more rapid onset of action than rapid-acting ...

India's CDSCO grants approval for Afrezza, an inhalable insulin spray, offering a needle-free alternative for diabetes management Afrezza provides a rapid, needle-free solution, ideal for patients ...